Devyser Diagnostics Holds Steady at SEK 50 Amid Mixed Peer Movements, Eyes Precision‑Medicine Growth
Devyser Diagnostics’ share price steadies near SEK 50 as precision‑medicine growth drives its DNA‑testing niche and market‑cap potential.
- DEVYSER DIAGNOSTICS AB
- Sweden
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read